History
The CoRRect Medical founding team has been introducing new innovative technologies into the German, Swiss and EU markets for the last 30 years. CoRRect Medical GmbH came into life after bundling this know-how.
The CoRRect Medical founding team has successfully introduced a range of products, including by the following partners:
ACIST Medical Systems, Inc. , Minneapolis, USA
successfully introduced into market.
(acquired by Bracco Group)
Arterial Vascular Engineering, Santa Rosa, USA
successfully introduced into market.
(acquired by Medtronic, NYSE: “MDT”)
Claret Medical Inc., Santa Rosa, USA
successfully introduced into market.
(acquired by Boston Scientific, NYSE: “BSX”)
CoreValve, Inc., Irvine, U.S.A.
successfully introduced into market.
(acquired by Medtronic, NYSE: “MDT”)
Embolic Protection, Inc., Menlo Park, USA
successfully introduced into market.
(acquired by Boston Scientific, NYSE: “BSX”)
Endologix, Inc., Irvine, USA
successfully introduced into market.
(IPO on NASDAQ: “ELGX”)
InterVentional Technologies, Inc., Irvine, USA
successfully introduced into market.
(acquired by Boston Scientific, NYSE: “BSX”)
MicroVena Corporation, Minneapolis, USA
successfully introduced into market.
(acquired by ev3, Inc., NASDAQ: “EVVV”)
ReCor Medical Inc., Palo Alto, USA
successfully introduced into market.
(acquired by Otsuka Pharmaceutical Co.Ltd, NASDAQ: “OTSKY”)
Vascular Solutions, Inc., Minneapolis, USA
successfully introduced into market.
(IPO on NASDAQ: “VASC”)
Additionally, selective investments have been made in new technologies as follows:
- Micrus Endovascular Corp., San Jose, USA (IPO on NASDAQ: “MEND”)
- Vascular Science, Inc., Minneapolis, USA (acquired by St. Jude Medical, NYSE: “STJ”)
Distribution companies created, built and exited successfully include the following:
- 1989 – 2002 Cardiologic GmbH (sold to Boston Scientific, NYSE: “BSX”)
- 1995 – 1999 MicroVena (Europa) GmbH (sold to MicroVena, Corp., Minneapolis, USA & later merged into ev3, Inc., NASDAQ: “EVVV”)
- 2003 – 2009 OVUM Ventures GmbH (sold to Medtronic, NYSE: “MDT”)